UNICA IRIS Institutional Research Information System

SOLLA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 142.756
NA - Nord America 6.827
AS - Asia 2.727
SA - Sud America 366
AF - Africa 52
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 6
Totale 152.758
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 140.874
US - Stati Uniti d'America 6.724
SG - Singapore 1.093
CN - Cina 1.088
UA - Ucraina 511
SE - Svezia 464
BR - Brasile 311
DE - Germania 235
GB - Regno Unito 199
FI - Finlandia 151
VN - Vietnam 151
KR - Corea 120
FR - Francia 91
CA - Canada 70
IN - India 66
NL - Olanda 40
JP - Giappone 34
RU - Federazione Russa 30
PL - Polonia 26
HK - Hong Kong 24
BE - Belgio 19
AR - Argentina 18
AT - Austria 18
MX - Messico 17
RO - Romania 17
BD - Bangladesh 16
IQ - Iraq 16
TR - Turchia 16
AU - Australia 15
ES - Italia 15
IL - Israele 15
IR - Iran 14
CZ - Repubblica Ceca 13
ZA - Sudafrica 12
CU - Cuba 11
MA - Marocco 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
PK - Pakistan 10
NZ - Nuova Zelanda 9
ID - Indonesia 8
IE - Irlanda 8
EC - Ecuador 7
CH - Svizzera 6
EU - Europa 6
GH - Ghana 6
JO - Giordania 6
LT - Lituania 6
VE - Venezuela 6
SA - Arabia Saudita 5
TW - Taiwan 5
UZ - Uzbekistan 5
DK - Danimarca 4
EE - Estonia 4
EG - Egitto 4
GR - Grecia 4
MY - Malesia 4
PY - Paraguay 4
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CO - Colombia 3
CY - Cipro 3
DZ - Algeria 3
LV - Lettonia 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
AO - Angola 2
HR - Croazia 2
IS - Islanda 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
ET - Etiopia 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
PR - Porto Rico 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 152.757
Salva come PNG Salva come JPEG
Città #
Cagliari 137.845
Uta 2.449
Fairfield 672
Ashburn 588
Woodbridge 583
Chandler 543
Singapore 495
Houston 357
Boardman 312
Wilmington 302
Nyköping 296
Dallas 286
Ann Arbor 267
Seattle 267
Beijing 260
Jacksonville 250
Cambridge 204
Dearborn 188
Los Angeles 125
Santa Clara 114
Nanjing 106
Shanghai 105
Hefei 80
Boston 74
Seoul 72
New York 71
Helsinki 65
Milan 53
Buffalo 51
Redwood City 51
San Diego 50
The Dalles 48
Ho Chi Minh City 37
Sassari 37
Rome 35
Shenyang 34
Atlanta 33
Toronto 33
Dong Ket 32
London 30
Changsha 29
São Paulo 29
Hanoi 27
Chicago 23
Nanchang 23
Redondo Beach 23
Frankfurt am Main 22
Jiaxing 21
Munich 21
Warsaw 21
Tianjin 20
Hong Kong 19
Mountain View 19
Brooklyn 18
Brussels 17
Norwalk 17
Phoenix 17
Verona 17
Hebei 15
San Francisco 15
Tokyo 15
Council Bluffs 14
Guangzhou 14
Icheon-si 14
Orange 14
Washington 14
Nuremberg 13
Rio de Janeiro 13
Wuhan 13
Zhengzhou 13
Chennai 12
Jinan 11
Montreal 11
Pune 11
Yongin-si 11
Amsterdam 10
Bari 10
Ningbo 10
Orem 10
Auburn Hills 9
Haiphong 9
Porto Alegre 9
Stockholm 9
Augusta 8
Casablanca 8
Da Nang 8
Deva 8
Leawood 8
Mumbai 8
San Mateo 8
Sestu 8
Belo Horizonte 7
Düsseldorf 7
Elk Grove Village 7
Johannesburg 7
Manchester 7
San Jose 7
Shenzhen 7
Tehran 7
Accra 6
Totale 148.308
Salva come PNG Salva come JPEG
Nome #
Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease 5.352
Drosophila model for parkinson’s disease: function, anatomy and screening with phytoterapics from Sardinian and Indian flora (Withania somnifera and Mucuna pruriens) 5.020
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: drug effects of Withania somnifera (Dunal) administration 4.981
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with Parkinson’s disease 4.425
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.249
OLFACTORY DYSFUNCTION AS POTENTIAL BIOMARKER IN NEURODEGENERATIVE DISORDERS 4.011
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 3.831
Impaired sense of smell in a Drosophila Parkinson's model. 3.593
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 3.502
Drosophila Parkinson's mutant display olfactory impairment both to natural and synthetic compounds 3.470
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.433
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.146
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.068
Olfactory function and apathy as potential biomarker in patients with Parkinson's disease 3.004
The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens 2.976
Olfactory function and age: a sniffin’ sticks extended test study performed in Sardinia 2.895
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 2.884
Influence of parkinsonism on Hitler's decision-making 2.882
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.479
Gender differences in olfactory function in patients with Parkinson's disease. 2.446
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion 2.338
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.252
Occurence and DAergic therapy correlates of REM sleep behavior disorder in patients with Parkinson Disease 2.138
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.113
Suicide and Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease 2.100
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.027
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 2.019
Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm 1.998
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 1.976
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 1.900
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.880
Discordance between Dopamine transporter deficit and motor symptoms in a case of REM sleep behavior disorder 1.856
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.848
Leucine-rich repeat kinase 2 (LRRK2) gene mutations in degenerative parkinsonism 1.644
null 1.548
Internal carotid artery dissection causing ischemic stroke during pole sport practice 1.542
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 1.538
Usefulness of levodopa in the treatment of patients affected by schizophrenia and parkinsonism with DAT scan suggestive of a severe presinaptic dopaminergic deficiency 1.485
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 1.411
null 1.368
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia 1.340
Clinical evaluation of sleep disorders in a large population of Parkinsonians 1.301
Towards the characterization of the role of neurosteroids in pathological gambling: Clinical and preclinical studies 1.293
Delayed effect of age at onset on disability progression in multiple sclerosis 1.282
Occurrence and Daergic therapy correlates of REM sleep behaviour disorder in a large population of patients with Parkinson's disease 1.266
Axonal Charcot-Marie-Tooth disease, distal hereditary motor neuropathy and spastic paraplegia in a large Sardinian family with Heat Shock Protein RW mutation: an expression of a common spectrum? 1.231
Analysis of parkin exon rearrangements and sequence variants in LRRK2 mutations carriers 1.092
Genetic analysis for five LRRK2 mutations in sardinian patients with familial or sporadic Parkinson’s disease 1.067
Factors Influencing Adaptation and Performance at Physical Exercise in Complex Congenital Heart Diseases after Surgical Repair 1.036
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 1.021
Occurance and Daergic therapy correlates of REM sleep behaviour disorder in a large population of patients with Parkinson's disease 1.007
Delusional jealousy in Parkinson's disease patients with and without dementia 1.002
Bipolar affective disorder and Parkinson's disease: a rare, insidious and often unrecognized association 978
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease. 929
Presence and severity of apathy in Sardinian patients affected by Parkinson’s disease and correlation with non-motor symptoms 911
Dopamine dysregulation syndrome in Parkinson's disease patients with unsatisfactory switching from immediate to extended release pramipexole: a further clue to incentive sensitization mechanisms? 877
Parkin sequence variants in Parkinson’s disease patients with LRRK2 mutations 869
Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient 859
Dopamine dysregulation syndrome in Parkinson's disease patients on duodenal levodopa infusion 853
Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients 832
Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study 807
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms 786
Sintomi non motori e disautonomia cardiovascolare in pazienti sardi affetti da malattia di parkinson con e senza mutazioni del gene LRRK2 763
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature 758
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 755
Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease 721
Rasagiline withdrawal Syndrome in Parkinson’s Disease 698
Finasteride attenuates pathological gambling in patients with Parkinson disease 695
null 692
Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson’s Disease 691
Olfactory hallucinations in Parkinson’s disease patients and the role of their evaluation in clinical practice. 605
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non‑tremor‑dominant subtypes really uncorrelated to olfactory impairment? 603
Othello syndrome in Parkinson disease patients without dementia 580
Gender-Related Differences in the Correlation between Odor Threshold, Discrimination, Identification, and Cognitive Reserve Index in Healthy Subjects 546
Pisa syndrome in a patient with progressive supranuclear palsy 541
Discordance between dopamine transporter deficit and motor symptoms in a case of REM behaviour disorder 540
Lateral trunk flexion and Pisa syndrome in Parkinson's disease. Are they really always different conditions although denoting similar features? 533
Dopaminergic-induced paraphilias associated with impulse control and related disorders in patients with Parkinson disease 533
Pathological gambling, delusional parasitosis and adipsia as a post-haemorrhagic syndrome: a case report 525
[123I] FP-CIT single photon emission computed tomography findings in drug-induced parkinsonism 521
Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment 520
Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation 501
Treatment of Benign Essential Blepharospasm With Finasteride: A Case Report 491
Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: a case report 476
Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients 471
[I-123]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 466
null 463
Exposure to TNF inhibitors is rare at MOGAD presentation 451
Motor and non-motor disorders in parkinsonian patients with LRRK2 mutations 447
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications 443
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations. 417
Epilepsy and sexual funtcion in male and female subjects treated with old and new AEDs, on poly or monotherapy: Preliminary data (Conference Paper) [Epilessia e funzione sessuale in pazienti di sesso maschile e femminile trattati con vecchi e nuovi FAE, in poli e monoterapia: Dati preliminari] 403
Role of rapid eye movement sleep behavior disorder (RBD) and other clinical factors in the prediction of cognitive impairment in Parkinson’s disease 392
Protein Tyrosine phosphatase receptor type C (CD45) C77G mutation and susceptibility to multiple sclerosis, autoimmune and infectious diseases 382
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo (R)) 378
Atypical parkinsonism in a patient with LRRK2 R1441c mutation 343
Dopaminergic replacement therapy enhances artistic productivity in patients with Parkinson's disease 327
Compulsive original artistic creativity in Parkinson's disease: a new dimension of the spectrum of reward-seeking behaviours 323
Dopaminergic drugs, paraphilic fantasies, paraphilic behaviours and creativity in Parkinson's disease 306
Olfactory Function as a Potential Predictor of Cognitive Impairment in Men and Women 304
Totale 150.871
Salva come PNG Salva come JPEG
Categoria #
all - tutte 193.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 193.201
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115.213 0 0 0 0 0 4.152 2.903 2.269 964 1.958 1.906 1.061
2021/20226.629 834 488 284 468 568 509 376 346 536 639 784 797
2022/20239.178 750 1.110 1.155 739 789 872 467 887 561 655 735 458
2023/202410.056 572 543 420 792 919 1.368 1.258 741 532 810 1.065 1.036
2024/202517.352 2.798 3.463 2.267 4.022 1.164 1.304 1.089 147 366 206 230 296
2025/20262.914 480 292 638 565 534 405 0 0 0 0 0 0
Totale 153.037